Drug Topics
SEPTEMBER 1, 2023
The FDA plans to finalize its ban on menthol tobacco products in the coming months, and the Department of Health and Human Services proposes comprehensive staffing requirements for nursing homes.
STAT
MAY 1, 2024
” At that point, he was living in a nursing home and had debilitating symptoms: tremors, difficulty gripping with his hands, and trouble walking. The FDA’s months-long internal examination of the LBP yielded a series of documents seen by STAT, including a lengthy review, completed in August 2019, of the Mount Sinai study.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
APRIL 6, 2021
UK digital health company Oxehealth has claimed FDA approval for software that can be used to remotely measure vital signs like heart and breathing rates from a camera feed. . The company says it will focus on deployment into skilled nursing facilities, of which there are around 15,500 in the US providing long-term care for more than 1.35
European Pharmaceutical Review
SEPTEMBER 29, 2022
The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme.
The Checkup by Singlecare
NOVEMBER 30, 2023
Prescription drug coverage Under the New York State Medicaid Pharmacy program (NYRx), FDA-approved and medically necessary drugs are eligible for coverage. Depending on your plan, you may get access to additional services. The long-term care must be ordered by a healthcare provider and approved by your Medicaid-managed care plan.
PharmaShots
MAY 10, 2023
On Oct 2022, Philips’s AI-enabled MRCAT Head and Neck received the FDA 510(K) approval from the US FDA for the treatment of Head and Neck Cancer. The company provides these products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and patients.
pharmaphorum
NOVEMBER 10, 2021
Nursing homes, dialysis centres, and long-term acute care hospitals all see considerable misuse and overuse of antimicrobials among patients who are, by definition, immunocompromised or infirm.”. “The The FDA should, then, establish a process and clear metrics to facilitate better tracking of antimicrobial consumption in animals.
Expert insights. Personalized for you.
247 
Let's personalize your content